亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢康寶泰精細化工有限公司武昌一分部  

精細化學品,化工中間體,原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付經理
  • 電話:027-87738651
  • QQ:664219562
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 25332-39-2 ***曲唑酮
25332-39-2 ***曲唑酮
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 10000千克起訂1千克
品牌 康寶泰
型號 25332-39-2
規格 25
過期 長期有效
更新 2013-11-25 13:29
 
詳細信息

中文名稱: ***曲唑酮
中文同義詞: ***曲唑酮;2-[3-[4-(3-氯苯基)-1-哌嗪基]丙基]-1,2,4-三唑[4,3-a]吡啶-3(2H)-酮***;曲唑酮***;2-[3-[4-(3-氯苯基)-1-哌嗪基]丙基-1,2,4-三唑并[4,;***曲唑酮/2-[3-[4-(3-氯苯基)-1-哌嗪基]丙基]-1,2,4-三唑[4,3-A]吡啶-3(2H)-酮***
英文名稱: Trazodone hydrochloride
英文同義詞: TRAZODONE HCL;TRAZODONE HYDROCHLORIDE;)-onehcl;2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2h;af1161;kb-831;molipaxin;pragmazone
CAS號: 25332-39-2
分子式: C19H23Cl2N5O
分子量: 408.32
EINECS號: 246-855-5
相關類別: Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol文件: 25332-39-2.mol
熔點  223-226?C
儲存條件  -20°C Freezer
溶解度  45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 23.3 mg/mL
 form  powder
 color  off-white
 CAS 數據庫 25332-39-2(CAS DataBase Reference)
***曲唑酮 用途:抗抑郁藥 ***曲唑酮屬三唑吡啶類抗抑郁藥,
©2025 武漢康寶泰精細化工有限公司武昌一分部 版權所有   技術支持:化工網   訪問量:26909  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |